Fingerprint
Dive into the research topics of 'Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization
Diana V. Do, Susan B. Bressler, Sandra D. Cassard, Emily W. Gower, Homayoun Tabandeh, Joan L. Jefferys, Neil M. Bressler
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations